Skip to content

Author

M. Cecchini

4 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Oct 2026

Risk of second primary malignancies in older long-term survivors of breast, prostate, colon, and rectal cancer.

BACKGROUND Cancer survivors face an increased risk of second primary malignancies (SPMs). Understanding SPM incidence and risk factors is crucial for long-term survivorship care. METHODS This was a SEER-Medicare retrospective cohort study of breast, prostate, colon, or rectal cancer survivors diagnosed between 2003-2...

Tendai Kwaramba, Sarah J. Westvold, Jessica B. Long et al. · 0 citations
Open access Oct 2026

Biomarker matched biologic use in patients with metastatic colorectal cancer (mCRC).

40 Background: The use of biologic therapy for patients with mCRC is incompletely characterized. We evaluated receipt of biomarker matched guideline concordant treatment with VEGF inhibitors (VEGFi), EGFR antibodies (EGFRa), and immune checkpoint inhibitors (ICI), assessing treatment by sociodemographic, clinic...

T. Salah, Jessica B. Long, John Rothen et al. · 0 citations
Open access Sep 2026

Clinical Significance of Tumor Infiltrating Lymphocytes and Modulation by Neoadjuvant Chemotherapy in Colorectal Cancer Liver Metastases

Simple Summary Colorectal cancer frequently spreads to the liver, where tumors resist immunotherapy through poorly understood mechanisms. Using quantitative multiplexed immunofluorescence in two independent patient cohorts, we measured CD4+, CD8+, and FOXP3+ regulatory T-cells in matched primary tumors and liver metast...

Yasaman Rezaie, Kerryan Ashley, J. Zhang et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.